Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02189525 · ClinicalTrials.gov registry record

Evaluation of Mild TBI in Collegiate Athletes

A clinical trial of Traumatic Brain Injury, sponsored by Banyan Biomarkers.

Completed
Registry status
500
Enrollment target
1
Study location

NCT02189525: Completed study of Traumatic Brain Injury, sponsored by Banyan Biomarkers.

NCT02189525 is a study of Traumatic Brain Injury that has completed, run by Banyan Biomarkers. The registered enrollment target is 500 participants, above the 274-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (82% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02189525, a study of Traumatic Brain Injury, has completed, sponsored by Banyan Biomarkers.

COMPLETED
Registry status
500 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate blood-based biomarkers before and after sports-induced concussion using neuroimaging and head impact sensor technology.

Conditions Studied

Study Locations (1)

Florida

  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2014-08
Est. Completion 2018-07-25
Banyan Biomarkers

8 total trials

What the finished NCT02189525 record still lists

NCT02189525 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 274-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (82% higher).

The record links to 1 condition, with Traumatic Brain Injury appearing as the primary indexed condition, and to 0 interventions.

NCT02189525 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT02189525 about?

NCT02189525 is a clinical study titled "Evaluation of Mild TBI in Collegiate Athletes". The purpose of this study is to evaluate blood-based biomarkers before and after sports-induced concussion using neuroimaging and head impact sensor technology.

What is the current status of trial NCT02189525?

This trial is currently completed. The enrollment target is 500 participants. The study started on 2014-08. Estimated completion is 2018-07-25.

What conditions does trial NCT02189525 study?

This clinical trial studies the following conditions: Traumatic Brain Injury.

Who is sponsoring clinical trial NCT02189525?

This trial is sponsored by Banyan Biomarkers, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02189525 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02189525's enrollment target sits among peer trials

500 14th of 171 higher than 157 of 171 other Traumatic Brain Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001230 · 500 participants

    Host Response to Infection and Treatment in Filarial Diseases

  • NCT00001529 · 500 participants

    Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

  • NCT00697411 · 500 participants

    Study of Selected X-Linked Disorders: Aicardi Syndrome

  • NCT00903110 · 500 participants

    Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02189525, the US trial registry maintained by the National Library of Medicine. NCT02189525 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.